Twitxy Saved

Eyestem

@EyestemResearch

Developing allogeneic cell therapies for degenerative diseases of the eye
Bengaluru South, India eyestem.com Joined September 2017
62 Following 416 Followers 243 Posts

Latest posts 5

Pinned post

Eyestem @EyestemResearch
We are incredibly excited to represent India on the global stage as part of @BharatInnov2026 !
Bharat Innovates Verified account @BharatInnovMoE May 16
Bharat Innovates 2026 proudly presents Eyestem, a pioneering Indian biotech startup transforming the future of regenerative medicine and vision restoration through advanced stem cell therapy. Based in Bengaluru, Eyestem is developing scalable and affordable cell replacement therapies for incurable retinal diseases such as Dry Age Related Macular Degeneration (AMD). Its flagship innovation, Eyecyte-RPE™, uses induced pluripotent stem cell (iPSC) technology to regenerate damaged retinal cells and potentially restore vision for millions worldwide.

As part of Bharat Innovates 2026, Eyestem will showcase its breakthrough healthcare innovations at the Final Showcase in Nice, France from 14–16 June 2026. With ongoing clinical trials, global investor backing, and a mission to democratize access to advanced therapies, Eyestem represents the next generation of Indian deep-tech innovation in healthcare and biotechnology.

The startup is not only advancing medical science but also bringing hope to patients battling incurable blindness across the globe.

@narendramodi @PMOIndia @eduminofindia @dpradhanbjp @PrinSciAdvGoI @Vineet_K26 @sanjayjavin @IndiaDST @AICTE_INDIA @ugcindia @pibindia @DDNewslive @airnewsalerts @sjaishankaroffc @Chatty111Prasad @MEABharat @IndiainPortugal @IndiaembFrance @CGIMarseille @eoiberlin @IndiainIreland @HCI_London @iitbombay @SINEIITB @paniitindia @EyestemResearch

#BharatInnovates2026 #Eyestem #Biotech #StemCellTherapy #HealthTech
View quoted post on X
Eyestem @EyestemResearch
We applied on 11th of Feb and money was in our account within 90 days !! Never seen such speed of execution in the public or private sector. Both our pitches were held on Sundays 😮 . Thank you @narendramodi @DrJitendraSingh @karandi65 @tdbgoi for the trust shown in us !
Dr Jitendra Singh Verified account @DrJitendraSingh May 16
Within just 6 months of the launch of Rs 1 lakh crore “Research, Development and Innovation” #RDI Fund Scheme by PM Sh @narendramodi, ₹50 crore was electronically disbursed under the scheme, reflecting the Government’s commitment to accelerate private sector participation in India’s R&D journey.

The First Agreement Signing with ETEs and the First Fund Release under the #RDIScheme, hosted by @tdbgoi, mark a significant step towards strengthening India’s innovation and deep-tech ecosystem.
View quoted post on X
Eyestem @EyestemResearch
With approval from CDSCO to move forward with our ph 2 randomized controlled trial, we move one critical step closer to eventual patient impact. m.economictimes.com/small-biz/sme-…
m.economictimes.com Eyestem receives CDSCO approval to initiate Phase 2 randomised, controlled human trials of Eyecyt... Eyestem Research has secured approval from India's CDSCO to begin Phase 2 clinical trials for its Eyecyte-RPE cell therapy. This treatment aims to address geographic atrophy, a condition causing...
Jogin Desai @jogin_desai Jan 29
Delighted to report approval from CDSCO to start ph 2 clinical trial of Eyecyte-RPE for treatment of Geographic Atrophy. With a stable surgical technique and good efficacy/safety data from ph one (14.8 ltrs at 6 M/14.6 ltrs at 12 M/No SAEs), we remain cautiously optimistic!
View quoted post on X